Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Colorectal Cancer
Interventions
PROCEDURE

Train the leaders course

Screening centre leaders randomized to the training intervention group will be invited to take part in a train-the-leaders course. The Train-the-leaders course will consist of three phases: (i) pre-training assessment, (ii) hands-on-training and (iii) post-training evaluation and feedback. The Train-the-leaders course will be run in polish by the team from the Maria Sklodowska-Curie Memorial Cancer Center and Institute on Oncology, Warsaw, which was trained in delivering such intervention by experts from the United Kingdom.

BEHAVIORAL

Audit and feedback

Screening centre leaders randomized to the feedback group will receive (by e-mail and conventional mail) feedback on their individual screening colonoscopy quality indicators (adenoma detection rate and ceacal intubation rate) measured for the 2011 edition of the national screening program. The results will be presented in a league table in order to enable comparison with anonymous results of all endoscopists who performed at least 30 colonoscopies within the screening program. In addition, a link to a webpage containing data on individual and overall colonoscopy quality indicators over the last four years of the screening program will be provided.

Trial Locations (1)

02-781

The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centre of Postgraduate Medical Education

OTHER

collaborator

Gloucestershire Hospitals NHS Foundation Trust

OTHER

collaborator

University of Oslo

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Ministry of Science and Higher Education, Poland

OTHER_GOV

lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER